Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2011 16:05 ET | Source: IRIS International, Inc.

IRIS International Announces Third Quarter 2011 Revenue and Financial Results

Record revenue of $28.1 million; 9% growth over Q3 2010 Gross margin of 50% in Q3 2011; Excluding Arista, gross margin of 52% Restructured Personalized Medicine Division by downsizing...
October 31, 2011 09:00 ET | Source: IRIS International, Inc.

IRIS International to Host Investor Breakfast December 2nd, 2011 In New York

CHATSWORTH, Calif., Oct. 31, 2011 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables, and a developer of...
October 26, 2011 18:43 ET | Source: IRIS International, Inc.

IRIS International Receives CE Mark for Its NADiA ProsVue(TM) Prognostic Cancer Test

CHATSWORTH, Calif., Oct. 26, 2011 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables, and a developer of...
October 17, 2011 16:10 ET | Source: IRIS International, Inc.

IRIS to Release Third Quarter Financial Results and Host Conference Call and Webcast on Thursday, November 3, 2011

CHATSWORTH, Calif., Oct. 17, 2011 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables, and a developer of...
October 14, 2011 16:15 ET | Source: IRIS International, Inc.

IRIS International Reports Granting of Inducement Awards

CHATSWORTH, Calif., Oct. 14, 2011 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and...
September 22, 2011 13:48 ET | Source: IRIS International, Inc.

IRIS International Receives FDA 510(k) Clearance for Its NADiA ProsVue(TM) Prognostic Cancer Test

CHATSWORTH, Calif., Sept. 22, 2011 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables, and a developer of...
September 07, 2011 16:05 ET | Source: IRIS International, Inc.

IRIS International Announces Restructuring of Personalized Medicine Division

Discontinuing non-proprietary testing services – flow cytometry, FISH, cytology services and molecular pathology menu Retaining CLIA license and commercial capabilities for the...
August 03, 2011 16:01 ET | Source: IRIS International, Inc.

IRIS International Announces Second Quarter 2011 Revenue and Financial Results

Record Revenue of $30.2 Million; 13% Growth Over Q2 2010 Gross Margin of 52% in Q2 2011 Net Loss of $0.3 Million or Diluted ($0.02) Per Share, Which Includes Arista Net...
July 26, 2011 07:00 ET | Source: IRIS International, Inc.

IRIS to Release Second Quarter Financial Results and Host Conference Call and Webcast on Wednesday, August 3, 2011

CHATSWORTH, Calif., July 26, 2011 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), will release its 2011 second quarter financial results after the close of trading on Wednesday, August 3,...
July 25, 2011 07:00 ET | Source: IRIS International, Inc.

IRIS Introduces the iRICELL(R)1500 Workcell for the U.S. Market at AACC 2011 Annual Meeting and Clinical Lab Expo

ATLANTA, July 25, 2011 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables, and a provider of high value...